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Table 1. Open versus laparoscopic donor nephrectomyLaparoscopic versus open
JH laparoscopic JH open RIH open
Donor statistics N 5 100 N 5 48 N 5 66donor nephrectomy
Hospital stay days 3.060.9 5.761.7 3.960.5
Parenteral narcotics days 3 5 3To the Editor: The recent discussion of laparoscopic
Oral narcotic use days 4 12 8
donor nephrectomy (Nephrology Forum) was informa- Return to work weeks 4.062.3 6.463.1 2–6
tive, but potentially biased as it failed to address many
JH laparoscopic JH open RIH open
of the arguments favoring open donor nephrectomy [1]. Recipient data N (%) N (%) N (%)
Furthermore, the results in Tables 1 and 3 do not reflect Hospital stay median days 7 7 5
Ureteral complications 10 (9.1) 3 (6.3) 1 (1.5)the current practice of open donor nephrectomy (ODN)
Vascular thrombosis 3 (2.7) 2 (4.2) 1 (1.5)at most institutions. The report inspired us to review the
Rejection in first month 32 (29) 15 (31) 2 (3)
results at our institution, some of which are presented Dialysis in first week 7 (6.4) 3 (6.2) 1 (1.5)
in Table 1. Operative complications following 66 ODN Abbreviations are: JH, Johns Hopkins; RIH, Rhode Island Hospital.
were limited to one wound infection and one pneumo-
thorax compared with a 14% complication rate reported
after laparoscopic donor nephrectomy.
Reply from the authors:In the UNOS Region 1, two centers have performed
more than 20 laparoscopic donor nephrectomies and no Dr. Morrissey and associates challenge our results re-
other center has performed ten. The early experience garding the advantages of a laparoscopic donor nephrec-
has been somewhat tumultuous, with reports of major tomy. The argument is based on personal experience
donor complications, including splenic injury requiring with their most recent 66 donors who are compared to
splenectomy and blood transfusion, perforation of the our initial cases with laparoscopic nephrectomy. Our
findings were based on a contemporary assessment fromcolon, and pulmonary embolism. Of primary concern
four years ago and parallel what other groups have re-in this venture is the well-being of the healthy donor.
ported [1, 2]. Nationwide there have been changes inLaparoscopic donor nephrectomy must be performed
practice patterns and as such, it is inappropriate to com-with a level of safety that mirrors the ODN experience.
pare the last 66 cases from Rhode Island Hospital to ourThere is no advantage to the recipient receiving a
previously published initial experience. Dr. Morrisseylaparoscopically procedured kidney. In fact, shorter re-
and associates do not give any information regarding thenal vessels may require complex implantation making
time period of these procedures, the previous experiencethe procedure somewhat more risky. The technical chal-
of the surgeons, their definition of complications, andlenge of the procedure is reflected in the high rates of
the general health of the recipients. Moreover, if theirdelayed graft function after the laparoscopic procedure.
data were collected retrospectively, many minor outpa-These concerns, along with an understanding of the cur-
tient complications that we have reported (such as UTI,rent results with ODN, should be considered in the public
transient thigh numbness during the global billing pe-debate and individual donor-recipient decisions regard-
riod) may have been missed. Our report utilized theing laparoscopic versus ODN.
same criteria within each group for critical care path-
ways, analgesic requirements, and criteria for returningPaul E. Morrissey, Peter N. Madras, Reg Y. Gohh,
and Anthony P. Monaco to work.
Providence, Rhode Island, USA Regarding recipient outcome, our published experi-
ence demonstrates vessel lengths comparable to thoseCorrespondence to Paul Morrissey, M.D., Transplant Services,
obtained during open harvest. Although there is a slightRhode Island Hospital, 593 Eddy Street, APC 921, Providence, Rhode
Island 02903, USA difference in the rate of decline of serum creatinine in
E-mail: pmorrissey@lifespan.org laparoscopic donors (1 day to reach nadir), this did not
affect hospitalization or ultimate graft function.
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Table 1. Annual decline in GFR (mL/min 3 1.73 m2 body surfacethe laparoscopic donor nephrectomy, complications de-
area per year) during 3.2 years of follow-up according
crease with surgical experience. There are methods to to smoking status
help shorten this learning curve, including the use of
Moderate Heavy Phand-assist devices and a team approach. Indeed, our Non-smokers smokers smokers (ANOVA)
success has been due to the close working relationship
Men 2.663.9 3.863.7 4.564.6 .0.20
between experienced laparoscopic and transplant sur- N 40 13 4
CGN 2.5 63.9 3.663.5 5.364.6 .0.20geons.
N 33 6 4
Lloyd Ratner, D, Robert Montgomery Data are mean 6 SD.
Definitions are: nonsmokers, never smokers and ex-smokers; moderate smok-and Louis R. Kavoussi
ers, smoking less than 25 g/day; heavy smokers, smoking more than 25 g/day;The Comprehensive Transplant Center
CGN, chronic glomerulonephritis.and Brady Urological Institute
Johns Hopkins Medical Institutions
Baltimore, Maryland, USA
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To the Editor: Smoking has recently been discussed as
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We performed a prospective study of 73 patients with
primary renal disease with the aim of evaluating the role
of renal dyslipidemia for the progression of renal failure
[4]. In a post-hoc analysis, smoking status (at entry) was The filtered complement
related to the decline in glomerular filtration rate (GFR).
There was no significant difference in the progression rate hypothesis
between smokers and nonsmokers during a three-year
To the Editor: In a recent Supplement to Kidney Inter-
national entitled, “Progression of Renal Disease: Proceed-
ings of the Verona Seminar on Nephrology” (Suppl 75,Ó 2000 by the International Society of Nephrology
